PURPOSE: This study was to identity the relationships between the side effects of depression and quality of sleep among gynecological cancer patients undergoing chemotherapy. METHODS: The data was collected from 113 patients at two general hospitals within B metropolitan city. The instruments used to collect the data for the study was the 'Side Effect Scale' developed by Kwon, Young-eun; 'Depression scale' developed by Oh, Se-man, and the 'Quality of Sleep Scale' developed by Oh, Song & Kim. RESULTS: Results showed that the mean of side effects was 39.75+/-9.99, mean of depression was 9.63+/-3.93 and mean of 'quality of sleep' was 36.99+/-6.66. The quality of sleep variable showed statistically significant differences for the variables: age (F=3.203, p=.026), cancer insurance (t=-2.278, p=.025), and perceived physical condition (F=3.152, p=.047) respectively. The relationship between side effects and quality of sleep showed a low negative, but significant correlation (r=-.327, p<.001). The relationship between depression and quality of sleep also showed a low negative correlation (r=-.365, p<.001). CONCLUSION: This study shows that it is necessary to develop nursing intervention programs because it can successfully improve the quality of sleep of gynecological cancer patients undergoing chemotherapy.
Depression ; Female ; Genital Neoplasms, Female ; Hospitals, General ; Humans ; Insurance ; Singing

PURPOSE: This study was to identity the relationships between the side effects of depression and quality of sleep among gynecological cancer patients undergoing chemotherapy. METHODS: The data was collected from 113 patients at two general hospitals within B metropolitan city. The instruments used to collect the data for the study was the 'Side Effect Scale' developed by Kwon, Young-eun; 'Depression scale' developed by Oh, Se-man, and the 'Quality of Sleep Scale' developed by Oh, Song & Kim. RESULTS: Results showed that the mean of side effects was 39.75+/-9.99, mean of depression was 9.63+/-3.93 and mean of 'quality of sleep' was 36.99+/-6.66. The quality of sleep variable showed statistically significant differences for the variables: age (F=3.203, p=.026), cancer insurance (t=-2.278, p=.025), and perceived physical condition (F=3.152, p=.047) respectively. The relationship between side effects and quality of sleep showed a low negative, but significant correlation (r=-.327, p<.001). The relationship between depression and quality of sleep also showed a low negative correlation (r=-.365, p<.001). CONCLUSION: This study shows that it is necessary to develop nursing intervention programs because it can successfully improve the quality of sleep of gynecological cancer patients undergoing chemotherapy.
Depression ; Female ; Genital Neoplasms, Female ; Hospitals, General ; Humans ; Insurance ; Singing

PURPOSE: The purpose of this study was to develop a web-based sexual health program for women undergoing treatment for gynecologic cancer and their partners, and to evaluate the validity of the developed program. METHODS: A web-based sexual health program was developed and evaluated: analysis (needs assessment on 23 patients and content analysis through literature review and web search), design, development, implementation, and evaluation. RESULTS: The web-based sexual health program for women undergoing treatment for gynecologic cancer and their partners was structured with sexual life, sexual response cycle, change of sexual function, sexual dysfunction related to treatment, and useful method for sexual dysfunction. This program included a video to improve for understanding and a bulletin board to promote bi-directional interactions between program users and providers. Experts and users rated this program in terms of efficacy, convenience, design, relevance, and usefulness. This program contents were found appropriate and satisfactory to both experts and users. CONCLUSION: This web-based sexual health program for women undergoing treatment for gynecologic cancer and their partners would contribute to sexual health promotion for gynecologic cancer women and their partners.
Female ; Genital Neoplasms, Female ; Humans ; Internet ; Methods ; Reproductive Health*

Female ; Genital Neoplasms, Female ; classification ; Humans ; World Health Organization

Highly transient population, multiple sexual partners and high prevalence of unprotected sex behaviors suggest a potential rapid spread of sexually transmitted diseases (STD) in China. However, there are some 200 non-sexually transmitted diseases involving the genitalia, etiologically falling into 23 types. To avoid unnecessary medical disputes, enough attention should be paid to the differential diagnosis of non-sexually transmitted diseases in the genitalia.
Female ; Genital Diseases, Female ; diagnosis ; etiology ; Genital Diseases, Male ; diagnosis ; etiology ; Genital Neoplasms, Male ; diagnosis ; Humans ; Male ; Skin Diseases, Infectious ; diagnosis ; etiology ; Skin Neoplasms ; diagnosis

The synchronous existence of endometrial cancer and cervical cancer is very rare. The reported frequency of concurrent gynecologic neoplasms has ranged from 0.7% to 4.3%, synchronous primary tumors of the female genital tract are relatively rare, comprising only 0.49% to 1.7% of all genital neoplasms. The majority of synchronous multiple primary neoplasm of female reproductive tract are of endometrial and ovarian origin. Multiple primary neoplams involving uterine cervix and endometrium were regarded as rare entity. We experienced a rare case of multiple primary neoplasm involving uterine cervix and endometrium and report with brief review of literatures.
Cervix Uteri ; Endometrial Neoplasms* ; Endometrium ; Female ; Genital Neoplasms, Female ; Humans ; Neoplasms, Multiple Primary ; Uterine Cervical Neoplasms*

OBJECTIVE: The measurement of tumor-associated antigen as tumor makers in the serum is useful for early diagnosis, differential diagnosis, and the determination of remission after therapy in cases of malignancy. A tumor-associated antigen is not always present in all the cells forming the tumor and also be detected in other tumors or normal organs. Tissue polypeptide antigen (TPA) is a single polypeptide chain without carbohydrate. TPA has immunosuppresive properties in patients with cancer. The aim of this study was to evaluate the clinical usefulness of the cytokeratin tumor marker TPA in early diagnosis of patients with the gynecologic cancer. METHODS: In this study, the levels of TPA were measured in the serum of 61 patients with benign gynecologic tumors, 24 patients with malignant gynecologic neoplasms, and 38 healthy nonpregnant females. Serum TPA level was measured by a "sandwitch technique based" radioimmunoassay. RESULTS: As a result, serum TPA level was 30.4+/-7.6 U/L in control group, 32.6+/-9.4 U/L in benign gynecologic tumor group, 39.1+/-9.8 U/L in malignant gynecologic neoplasm. Serum TPA level was 56.6+/-7.0 U/L in ovarian cancer group. CONCLUSION: Serum levels of TPA was increased in the ovarian cancer group, but it does not seem to be a useful tumor maker for non-ovarian cancer. It would seem that measurement of TPA is useful for early diagnosis of ovarian cancer.
Diagnosis, Differential ; Early Diagnosis ; Female ; Genital Neoplasms, Female ; Humans ; Keratins ; Ovarian Neoplasms ; Radioimmunoassay ; Tissue Polypeptide Antigen*

No abstract available.
Asia ; Female ; Genital Neoplasms, Female/*therapy ; Humans ; Ovarian Neoplasms/therapy ; Societies, Medical

A radical hysterectomy was performed on patients with stage IA2 to IIB cervical cancer. For these patients, many histopathological parameters have been reported to be prognostic factors of cervical cancer, such as a pelvic lymph node (PLN) metastasis, the histological subtype, the tumor diameter, the depth of the stromal invasion, a lymph-vascular space invasion (LVSI), a parametrial invasion, a corpus invasion and a vaginal invasion. Ovarian cancer is normally treated with cytoreductive surgery followed by chemotherapy. Although physicians have paid a great deal of attention to intraperitoneal disease, a substantial number of ovarian cancers have reported to involve the retroperitoneal lymph nodes. Therefore, a lymph node metastasis has been introduced into FIGO staging. However, the prognostic significance of a lymph node metastasis is controversial. In order to determine the possibility of individualizing a pelvic lymph node (PLN) dissection in patients with endometrial cancer, the relationship between PLN metastasis and the various prognostic factors was investigated. In this paper, various prognostic variables including a lymph node metastasis were analyzed in cervical cancer, enodometrial cancer, and ovarian cancer.
Cervix Neoplasms/pathology ; Endometrial Neoplasms/pathology ; Female ; Genital Neoplasms, Female/*pathology ; Human ; Lymphatic Metastasis ; Ovarian Neoplasms/pathology

It is often difficult to conclude that improvements in survival with time are due to a screening programme alone. Although a reduction in the death rate from a given cancer may reflect the benefits of early detection or improved treatment, the benefits may also result from lead time bias and over-diagnosis, the former resulting in longer survival of screen-identified cancers because the time before the cancer would have been clinically diagnosed is included in calculations. Furthermore, recent reviews on randomised clinical trials of cancer screening have provided strong evidence that misclassifications in causes of death have been a major problem, leading to an over-estimation of the effectiveness (or alternatively an under-estimation of potential harm) of screening.
Cervix Neoplasms/*diagnosis ; Endometrial Neoplasms/diagnosis ; Female ; Genital Neoplasms, Female/*diagnosis/epidemiology/mortality ; Human ; Incidence ; Ovarian Neoplasms/diagnosis ; Risk